Market Leadership Encube Ethicals operates the world’s largest single-site topical manufacturing facility, highlighting its strong market presence and capacity, making it an ideal partner for large-volume pharmaceutical and cosmetic companies seeking reliable supply chain solutions.

Innovation Focus With a dedicated R&D centre housing over 150 scientists and strategic partnerships such as with Lodha Group, Encube emphasizes innovation and infrastructure expansion, presenting opportunities for collaborative formulation development and custom product solutions.

Financial Strength Having secured substantial funding of $110 million and generating revenues between $50 million and $100 million, Encube is financially well-positioned to invest in new product lines, technology upgrades, and strategic alliances that can benefit potential partners.

Expansion Strategy Recent collaborations with investors like Quadria Capital and co-investors suggest a proactive growth approach, offering prospects for joint ventures, co-development projects, and entry into new markets within the topical pharmaceutical sector.

Technology Utilization Encube's use of advanced technological tools and secure infrastructure, including modern security protocols and web technologies, signals readiness for digital partnerships, tech-enabled supply chain solutions, and innovative pharmaceutical service offerings.